Summit Therapeutics Inc

Research Summit Therapeutics Inc (SMMT) on Bullrun: market cap USD 11.11B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSMMT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 11.11B
• Financial periodFY2025
• Net income-USD 1.08B
• Free cash flow-USD 323.59M

Valuation Snapshot

latest market cap is USD 11.11B.

About Summit Therapeutics Inc

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC).

Frequently asked questions

What is Summit Therapeutics Inc's market cap?

Summit Therapeutics Inc's market capitalization is USD 11.11B.

What does Summit Therapeutics Inc do?

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.